Clinical predictors of response to EGFR-tyrosine kinase inhibitors in EGFR-mutated non-small cell lung cancer: a real-world multicentric cohort analysis from India

A Garg, U Batra, P Choudhary, D Jain… - Current Problems in …, 2020 - Elsevier
Background: The development of various targeted therapies against Epidermal Growth
Factor Receptor (EGFR) has been a major step in therapeutic advancements in lung cancer …
被引用次数：18 相关文章

Clinical predictors of response to EGFR-tyrosine kinase inhibitors in EGFR-mutated non-small cell lung cancer: A real-world multicentric cohort analysis from India.

A Garg, U Batra, P Choudhary, D Jain… - Current Problems in …, 2020 - europepmc.org
Background The development of various targeted therapies against Epidermal Growth
Factor Receptor (EGFR) has been a major step in therapeutic advancements in lung cancer …

Clinical predictors of response to EGFR-tyrosine kinase inhibitors in EGFR-mutated non-small cell lung cancer: A real-world multicentric cohort analysis from India

A Garg, U Batra, P Choudhary, D Jain… - Current Problems in …, 2020 - Elsevier
Background: The development of various targeted therapies against Epidermal Growth
Factor Receptor (EGFR) has been a major step in therapeutic advancements in lung cancer …

Clinical predictors of response to EGFR-tyrosine kinase inhibitors in EGFR-mutated non-small cell lung cancer: A real-world multicentric cohort analysis from India

A Garg, U Batra, P Choudhary… - Current problems …, 2020 - pubmed.ncbi.nlm.nih.gov
Background The development of various targeted therapies against Epidermal Growth
Factor Receptor (EGFR) has been a major step in therapeutic advancements in lung cancer …